Company page

Cytokinetics, Incorporated

Cytokinetics, Incorporated (ticker: CYTK) is a public company based in the United States, with a market capitalization of approximately $9.8 billion. The company focuses on developing innovative treatments for serious diseases, particularly in the fields of muscle biology and neuromuscular diseases. Cytokinetics aims to advance its pipeline of therapeutic candidates to improve patient outcomes.